Literature DB >> 12963977

Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy.

Malini Olivo1, Weber Lau, Vanaja Manivasager, Puay Hoon Tan, Khee Chee Soo, Christopher Cheng.   

Abstract

The early detection of carcinoma is very essential for the diagnosis and prognosis of a bladder cancer patient. In this study we have investigated the use of hypericin as a fluorescent tumour marker and laser confocal microscopy as a diagnostic tool to aid the diagnosis of such cancers. Both cellular and clinical studies have been conducted. In the cellular studies, we have compared two bladder cell lines for the uptake and sub-cellular localization of hypericin. It was found that there was a rapid uptake and clearance of hypericin and significant localization in mitochondria and lysosomes. The study also revealed that there was a time-dependent increase in fluorescence intensity in bladder cells. The optimum localization was found to be 2-4 h post drug incubation. In the clinical study, consisting of 30 patients, both white light and fluorescence cystoscopy were performed after hypericin instillation. Biopsies taken from fluorescing regions were imaged using the confocal microscope. The order of fluorescence was detected to be as follows: normal < inflammation < grade 1 < grade 2 < CIS < grade 3. It was also found that the fluorescence intensity increased with the stage of the disease thereby enabling the determination of the degree of invasiveness of cancer. This enables the use of hypericin as a prognostic marker and laser confocal microscopy as a tool to aid in diagnosis of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963977

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

Review 1.  New frontier in hypericin-mediated diagnosis of cancer with current optical technologies.

Authors:  Malini Olivo; Chit Yaw Fu; Vijaya Raghavan; Weber Kam On Lau
Journal:  Ann Biomed Eng       Date:  2011-11-29       Impact factor: 3.934

2.  Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio.

Authors:  Jingwen Yi; Xiaoguang Yang; Lihua Zheng; Guang Yang; Luguo Sun; Yongli Bao; Yin Wu; Yanxin Huang; Chunlei Yu; Shao-Nian Yang; Yuxin Li
Journal:  Biosci Rep       Date:  2015-04-20       Impact factor: 3.840

3.  A Model In Vitro Study Using Hypericin: Tumor-Versus Necrosis-Targeting Property and Possible Mechanisms.

Authors:  Yue Li; Shuncong Wang; Yuanyu Zhao; Hexige Saiyin; Xiaoyan He; Juanzhi Zhao; Ling Li; Ali Talebi; Gang Huang; Yicheng Ni
Journal:  Biology (Basel)       Date:  2020-01-07

4.  Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.

Authors:  Ramaswamy Bhuvaneswari; Yik Y Gan; Sasidharan S Lucky; William W L Chin; Seyed M Ali; Khee C Soo; Malini Olivo
Journal:  Mol Cancer       Date:  2008-06-13       Impact factor: 27.401

Review 5.  Hypericin in the Light and in the Dark: Two Sides of the Same Coin.

Authors:  Zuzana Jendželovská; Rastislav Jendželovský; Barbora Kuchárová; Peter Fedoročko
Journal:  Front Plant Sci       Date:  2016-05-06       Impact factor: 5.753

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.